Exhibit 10.27

 

 

 

 

February 23, 2021

 

David Humphrey

Via email:

 

Re: Offer Letter February 11, 2021 Amendment

 

Dear Dave:

 

This letter is to amend the Equity Award language of the fully executed February 11, 2021 Offer Letter from “Once the contemplated merger transaction closes you will be provided a stock option grant in a quantity representing 1.0% of the merged Company’s newly formed Equity Incentive Plan (the “Plan”). To “Once the contemplated merger transaction closes you will be provided a stock option grant of 275,000 shares of the merged Company’s newly formed Equity Incentive Plan (the “Plan”).

 

All other language in the February 11, 2021 Offer letter will remain the same.

 

Sincerely,

 

/s/ Lynn Kirkpatrick  
Lynn Kirkpatrick  
Chief Executive Officer  

 

Acknowledged:

 

/s/ David Humphrey  
Dave Humphrey  

 

02/23/2021

Date

 

Ensysce Biosciences Inc.

7946 Ivanhoe Ave. Ste 201 - La Jolla, CA – 92037 www.ensysce.com